ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0844

Dengue Virus Infection as a Trigger for Collapsing Glomerulopathy in a Patient with an APOL1 High-Risk Genotype

Session Information

Category: Glomerular Diseases

  • 1402 Glomerular Diseases: Clinical, Outcomes, and Therapeutics

Authors

  • Ribeiro, Andressa, Universidade de Sao Paulo, São Paulo, SP, Brazil
  • Neves, Precil D., Universidade de Sao Paulo, São Paulo, SP, Brazil
  • Mariussi, Pedro M., Universidade de Sao Paulo, São Paulo, SP, Brazil
  • Oliveira, Felipe Augusto, Universidade de Sao Paulo, São Paulo, SP, Brazil
  • Alberti, Matheus Noronha, Universidade de Sao Paulo, São Paulo, SP, Brazil
  • Noronha, Irene L., Universidade de Sao Paulo, São Paulo, SP, Brazil
  • Vieira Jr., Jose M., Universidade de Sao Paulo, São Paulo, SP, Brazil
  • Ledesma, Felipe Lourenco, Universidade de Sao Paulo, São Paulo, SP, Brazil
Introduction

Collapsing Glomerulopathy (CG) is a severe kidney disease with a fast progression to chronic kidney disease requiring renal replacement therapy (CKD-KRT). We report the first case of CG associated with Dengue (DENV) in a patient with APOL1 high-risk genotype (APOL1-HRG).

Case Description

A 41-year-old black female, previously diagnosed with sickle cell anemia, hypertension, and CKD stage 3A was admitted with a 6-day history of fever, headache, nausea, and oliguria. An NS1 antigen-test for DENV resulted positive. On physical examination, the patient had lower limbs edema and hypertension. She was on use of hydroxyurea, enalapril and folic acid. Laboratory tests showed Hb: 7.8g/dL, platelets: 65,000/mm3, DHL: 1442U/L, AST: 609U/L, ALT: 350U/L. albumin: 2.5g/dL, Ur: 83mg/dl, Cr: 6.7mg/dL, mild metabolic acidosis and no electrolyte disturbances. Urinalysis revealed hematuria and 24h-proteinuria: 50g. A kidney biopsy revealed at light microscopy 6 out of 17 globally sclerotic glomeruli, global collapse of the capillary loop associated with podocyte hyperplasia and hypertrophy. Interstitial fibrosis / tubular atrophy quantified in 30% of the compartment. Immunofluorescence stained for C3 2+/3+, with a granular pattern and global and focal distribution (trapping). These findings corroborate the diagnosis of Collapsing Glomerulopathy. She harbors an APOL1-HRG (G1/G1). The patient started on hemodialysis and has been treated with pulse of methylprednisolone 500 mg for 3 days, followed by prednisone 80 mg and mycophenolate 2 g/day. One month after treatment start, the patient improved renal function, and was discharged from hospital with an eGFR 20ml/min/1.73m2

Discussion

Viral infections are frequent triggers for GC in patients with APOL1-HRG. In tropical countries, arboviruses such as DENV, Zika and Chikungunya should also be investigated in patients with GC, especially if they carry APOL1-HRG.

Digital Object Identifier (DOI)